Immediate effects of intravenous verapamil in cardiac arrhythmias.
about
The "top 50": a perspective on the BMJ drawn from the Science Citation IndexEffect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardiaResponse of recurrent sustained ventricular tachycardia to verapamilSelective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathwaysEffects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.Cardiac mitochondria and arrhythmias.Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutterThe relative effects of digoxin and diltiazem upon ventricular ectopic activity in patients with chronic atrial fibrillation.Calcium antagonists and their mode of action: an historical overview.Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).Two or more intra AV nodal pathways in association with either a James or Kent extranodal bypass in 3 patients with paroxysmal supraventricular tachycardia.Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.Differential effects of the calcium antagonist, verapamil, on lumen sizes of terminal arterioles and muscular venules in the rat mesenteric, pial and skeletal muscle microvasculaturesEffect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.Verapamil in the treatment of paroxysmal supraventricular tachycardia.Verapamil and the myocardium.Taboparesis: Lown-Ganong-Levine syndrome.Electrocardiography then and now: where next?Stereoselectivity: an issue of significant importance in clinical pharmacology.Controlled-release formulations of propranolol and verapamil.Verapamil in arrhythmiaAntiarrhythmic effects of verapamil.Calcium antagonists: A new class of therapeutic agents.Role of calcium antagonists in cardiovascular therapy.Dimeditiapramine (Ro 11-1781), a new calcium antagonist, in the management of supraventricular tachyarrhythmias in patients with acute myocardial infarction.Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.Somatostatin in the human heart and comparison with guinea pig and rat heart.A comparison of verapamil and digoxin for heart rate control in atrial fibrillation.Selecting a calcium channel-blocking agent.Verapamil and morphineThe effect of Verapamil on the cardiac conduction system in man.Cerebral infarction associated with oral verapamil overdose.Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator† †Electronic supplementary information (ESI) available. See DOI: 10.1039/C7TX00141J.Early afterdepolarisation tendency as a simulated pro-arrhythmic risk indicator.The peri-operative management of atrial fibrillation.Tarka® overdose in a young child.
P2860
Q24678708-DC0D63D2-EB97-4B59-B11A-5E0A947BD075Q28333056-D367508E-E3D3-4F6D-A010-E561263E6AA8Q28366991-5B29BC1A-D176-4373-838B-714974DC1133Q28367490-CF8FA3B7-7086-43C3-93BF-B10447A68FA0Q33821933-72BF8EA3-6A54-4B00-B587-EDDA3E0E797DQ34307966-B57C3FA4-02A5-472D-874E-946C89131024Q34346684-83902FC8-D71E-4FDE-9D31-9BA77971A081Q34418003-3CF64A73-55A4-4867-BE0E-CE0829F4F77FQ34446780-E67A6E42-B160-4128-8D53-A19450459AD6Q35644676-CD550687-36F6-4335-9EDB-D9DD3796D7C9Q35885320-421C81A5-DB48-46E4-AE20-4C0365BB00F8Q36099398-3A9427A2-2A72-49A0-8619-D7231C044C28Q36105967-E0AF6F1A-F5E2-4949-8BDE-01BEACA5A497Q36667824-32DDD9E9-FF04-476D-A45B-35838D845D92Q36766509-34AFB80F-41C8-4109-B57E-D0A2B3BF8CDBQ36774881-1F6976E7-F90E-49BB-A321-BB1FF692E237Q36810365-74C878DE-2B8C-4788-8334-1A703285B282Q36810369-1C8F5A3B-FB03-4153-AAB2-F070AA570A3DQ39368023-D0D83D67-2FBE-4C7D-99A4-922641135782Q39503760-A43D9566-4290-4C6E-8A63-A0E9133088ABQ39529348-80799048-8C90-4DDD-BCB4-598272B6D409Q39679813-C1760FB2-7194-4D8E-8422-E10E750F2CDAQ39743026-9302AC82-1417-4C95-953D-D5370783D9C9Q40157037-3992B17C-FAB8-41D0-AF0C-81B161FB4628Q40303209-4030E63D-E973-4A2D-AB7F-631ACC512DB7Q40313183-3D50A598-ED4E-42F5-A6FF-FAE025FC57EEQ40463162-6775F80F-9B0C-4697-B8A0-C9A284F5BFF5Q41115698-E5E07CFC-6B24-41B2-9064-CC0733425422Q41308594-AEBD0CAD-73D7-40A8-ABE8-DCDED05C8416Q42102218-E89A2039-7416-4568-AC89-B9AC65FA71A6Q42138817-F704E85A-E92C-45E9-B2D9-20C5E0ADF887Q42274340-CC9BC8CE-618A-4BC1-8D07-3BAA96B56045Q45823831-E123A889-17E8-4601-9747-C150BBD1E5A3Q48147720-C17F4571-8CBC-42A9-B08C-63A2D42F795AQ49588968-02D3EC07-F407-42DA-B36B-A11FDC93CCBCQ49874081-47300630-63AD-4F4E-9469-9D734A26C22CQ51498351-0B7F91AA-9017-44BE-B1A9-EFBE6DD4499EQ51528878-DBBE43A3-D629-4230-9FD4-E93090D13B19
P2860
Immediate effects of intravenous verapamil in cardiac arrhythmias.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh-hant
name
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@en
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@nl
type
label
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@en
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@nl
prefLabel
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@en
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@nl
P2093
P2860
P356
P1433
P1476
Immediate effects of intravenous verapamil in cardiac arrhythmias.
@en
P2093
Krikler DM
Schamroth L
P2860
P304
P356
10.1136/BMJ.1.5801.660
P407
P577
1972-03-01T00:00:00Z